Posted on August 14th, 2009 in Swine Flu
Inovio has two flu vaccines at late stages of the product pipeline. Their VGX-3400 and its universal influenza vaccine have also shown positive results during development and trial stages. However, other companies like AVI BioPharma (AVII) and Antigenics (AGEN) might win the race for the first swine flu vaccine
Tags: AGEN, Antigenics, Astrazeneca, Avi biopharma, avii, AZN, BioMedical, Biopharma, biotech companies, bird flu virus, DNA vaccine, DNA vaccines, flu vaccines, flu virus strains, GlazoSmithKline, GSK, H1N1 virus, h1n1 virus strain, influenza strains, influenza vaccine, Inovio BioMedical, Inovio BioMedical Corp, Inovio BioMedical Corporation, Inovio INO, Inovio SciCon, Inovio Swine Flu, pharmaceutical companies, pharmaceutical industry, Swine flu stocks, swine flu stocks to watch, swine flu virus, Top Pharmaceutical Companies, VGX-3400, virus strain